Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 106

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 106
---
 at the Special Meeting, it is expected that the Special Meeting will be adjourned or postponed to solicit additional attendance.

63

Required Vote

Approval of the Arrangement Resolution requires the affirmative vote of not less than (i) 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting, and (ii) a simple majority of the votes attached to Common Shares held by Shareholders
present in person (virtually) or represented by proxy at the Special Meeting excluding for this purpose votes attached to Common Shares held by persons described in items (a) through (d) of section 8.1(2) of MI
61-101. See “Interests of the Company’s Directors and Executive Officers inthe Arrangement — Canadian Securities Law Matters” for more information. As of
November 21, 2025, the Record Date, there were 43,108,362 Common Shares issued and outstanding.

Approval of the Compensation
Resolution requires the affirmative vote of a majority of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special meeting. Approval of the Liquidation Resolution requires the affirmative vote of not less
than 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special Meeting. Approval of the Liquidator Resolution
requires the affirmative vote of not less than 66⁄% of the votes cast by Shareholders present in person (virtually) or represented by proxy at the Special
Meeting.

Solicitation of Proxies

The Company is providing this Circular and Proxy Statement and a form of proxy in connection with management’s solicitation of proxies
for use at the Special Meeting and at any postponement(s) or adjournment(s) thereof. The solicitation of proxies for the Special Meeting will be made primarily by mail, but proxies may also be solicited personally or by telephone, email, internet,
facsimile transmission or other electronic or other means of communication by directors, officers, employees, agents or other Representatives. The cost of solicitation by management of the Company will be borne directly by the Company. The Company
will reimburse Intermediaries for permitted fees and costs incurred by them in mailing soliciting materials to the Beneficial Shareholders. Invoices for such permitted fees and costs should be directed to the attention of the Chief Financial Officer
of the Company at 7171 Frederick-Banting, Building